Last updated: 2026-10-12 16:33:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Solventum Corporation (SOLV) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $85.58, with a market capitalisation of $14.86B and a P/E ratio of 10.36. Over the past 52 weeks, its price has ranged from $62.38 to $94.16. This page covers its latest market performance, valuation, price trends and company information.
$14.86B | |
$87.00 | |
$94.16 | |
$47.16 | |
$87.29 | |
629.44K | |
1.04M | |
10.36 | |
$94.16 | |
$62.38 | |
-- | |
-- |
Solventum Corporation (SOLV) is currently trading at $85.58 as of 2026-10-12 16:16:14, down 1.96% ($1.72) from the previous close of $87.29
During today's regular trading session, SOLV has traded between $47.16 and $94.16, with a trading volume of 629.44K shares. The current price is near the upper end of today's range.
Over the past seven days, Solventum Corporation (SOLV) moved from $87.77 to $85.58, representing a decline of 2.50% ($2.19).
The stock traded between $84.55 and $89.03 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 993.55 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 73.0%
SOLV is currently trading at $85.58, placing it 73.0% of the way from its 52-week low of $62.38 to its 52-week high of $94.16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 20000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Solventum Corporation (SOLV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.